鋭明技術(002970.SZ):自主研發涉及自動駕駛業務中的AEBS已經落地銷售
格隆匯3月18日丨鋭明技術(002970.SZ)近日在接待機構投資者調研時表示,公司自主研發涉及自動駕駛業務中的AEBS已經落地銷售,深圳出租的AEBS項目在業內已成為標杆項目,在全國產生了良好的示範效應,得到各地出租行業的關注和學習;公交車的AEBS業務也開始量產銷售。目前,公司已將出租車及公交車的AEBS業務引入海外市場,這將有助於海外業務的進一步增長,公司仍在深度研究其它商用車行業的AEBS等應用場景,為公司穩健發展提前謀劃佈局中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.